Cite
Plasma Androgen Receptor and Docetaxel for Metastatic Castration-resistant Prostate Cancer
MLA
Vincenza Conteduca, et al. “Plasma Androgen Receptor and Docetaxel for Metastatic Castration-Resistant Prostate Cancer.” European Urology, vol. 75, no. 3, Jan. 2019, pp. 368–73. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid.dedup....5a3b2d792bd066c01c1b2f901c9f01ab&authtype=sso&custid=ns315887.
APA
Vincenza Conteduca, Jayaram, A., Romero-Laorden, N., Wetterskog, D., Salvi, S., Gurioli, G., Scarpi, E., Castro, E., Marin-Aguilera, M., Lolli, C., Schepisi, G., Maugeri, A., Wingate, A., Farolfi, A., Casadio, V., Medina, A., Puente, J., Vidal, M., Morales-Barrera, R., … Giorgi, U. (2019). Plasma Androgen Receptor and Docetaxel for Metastatic Castration-resistant Prostate Cancer. European Urology, 75(3), 368–373.
Chicago
Vincenza Conteduca, A. Jayaram, N. Romero-Laorden, D. Wetterskog, S. Salvi, G. Gurioli, E. Scarpi, et al. 2019. “Plasma Androgen Receptor and Docetaxel for Metastatic Castration-Resistant Prostate Cancer.” European Urology 75 (3): 368–73. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid.dedup....5a3b2d792bd066c01c1b2f901c9f01ab&authtype=sso&custid=ns315887.